Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases

Bisphosphonates are potent antiresorptive agents used for a spectrum of metabolic bone diseases. The aim of this study was to compare the adverse effects (AEs) of alendronate, etidronate and risedronate prescribed in a non-selected population, attending a single institution on an outpatient basis. 8...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hormones (Athens, Greece) Greece), 2007-07, Vol.6 (3), p.233
Hauptverfasser:	Anastasilakis, Athanasios D, Goulis, Dimitrios G, Kita, Marina, Avramidis, Avraam
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Alendronate - administration & dosage Alendronate - adverse effects Bone Density Conservation Agents - administration & dosage Bone Density Conservation Agents - adverse effects Diphosphonates - administration & dosage Diphosphonates - adverse effects Etidronic Acid - administration & dosage Etidronic Acid - adverse effects Etidronic Acid - analogs & derivatives Gastrointestinal Diseases - chemically induced Humans Middle Aged Osteoporosis, Postmenopausal - drug therapy Risedronate Sodium Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!